CRDF

CRDF Operating Expenses

$42.77MTTM · USD

Period ending:

CRDF FY Operating ExpensesUSD
CRDF FY Operating Expenses2005-01-31: $1.27M2006-01-31: $4.41M2009-12-31: $3.05M2010-12-31: $5.64M2011-12-31: $3.23M2012-12-31: $5.30M2013-12-31: $10.95M2014-12-31: $15.21M2015-12-31: $24.96M2016-12-31: $38.01M2017-12-31: $22.12M2018-12-31: $16.17M2019-12-31: $16.92M2020-12-31: $19.45M2021-12-31: $29.21M2022-12-31: $40.29M2023-12-31: $45.90M2024-12-31: $49.33M2025-12-31: $49.55M$49.55M$0.00
2005-01-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CRDF operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 19 observations from Jan 31, 2005 to Dec 31, 2025.

Cardiff Oncology Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
49,553,000
49,334,000
45,900,000
40,288,000
29,214,000
19,452,000
16,923,126
16,170,000
22,115,000
38,006,000
24,958,000
15,210,000
10,949,787
5,299,000
3,234,499
5,644,953
3,050,000
4,409,327
1,271,330

Compare operating expenses

All CRDF financial metrics · CRDF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.